#BEGIN_DRUGCARD DB08603

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C14H21ClN2O3S

# Chemical_IUPAC_Name:
(3S)-7-amino-1-chloro-S-(4-methylphenyl)-2-oxoheptane-3-sulfonamido

# Chemical_Structure:
Not Available

# Creation_Date:
2010-09-15 15:33:08 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide

# HET_ID:
TCK

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C14H21ClN2O3S/c1-11-5-7-12(8-6-11)21(19,20)17-13(14(18)10-15)4-2-3-9-16/h5-8,13,17H,2-4,9-10,16H2,1H3/t13-/m0/s1

# InChI_Key:
InChIKey=RDFCSSHDJSZMTQ-ZDUSSCGKSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
8609

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
332.846

# Molecular_Weight_Mono:
332.096140945

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.82

# Predicted_LogS:
-3.8

# Predicted_Water_Solubility:
5.50e-02 g/l

# Primary_Accession_No:
DB08603

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
73094

# PubChem_Substance_ID:
99445074

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@@](CCCCN)(NS(=O)(=O)C1=CC=C(C)C=C1)C(=O)CCl

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:27:03 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Secreted

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
J05128

# Drug_Target_1_GenBank_ID_Protein:
141804

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>1962 bp
ACATCACGGACGGAGACAAGCAATGAAACGCATTTGTGGTTCCCTGCTGTTGCTCGGTTT
GTCGATCAGCGCCGCGCTCGCCGCCCCGGCCTCGCGCCCCGCGGCGTTCGATTACGCCAA
TCTTTCCAGCGTCGACAAGGTCGCCTTGCGCACCATGCCGGCGGTCGACGTGGCCAAGGC
CAAGGCCGAAGATTTGCAGCGCGACAAGCGCGGCGACATCCCGCGCTTCGCCCTGGCGAT
CGACGTGGACATGACCCCTCAGAATTCCGGCGCGTGGGAATACACCGCCGACGGCCAGTT
CGCCGTATGGCGCCAGCGCGTTCGTTCGGAGAAGGCGCTGTCACTGAACTTCGGTTTCAC
CGACTACTACATGCCCGCCGGCGGCCGCCTGCTGGTATATCCGGCGACTCAGGCGCCGGC
CGGCGATCGCGGCTTGATCAGCCAGTACGACGCCAGCAACAACAACTCGGCGCGCCAACT
GTGGACGGCGGTGGTGCCGGGCGCCGAAGCGGTGATCGAAGCGGTGATCCCGCGCGACAA
GGTCGGCGAGTTCAAGCTGCGCCTGACCAAGGTCAACCACGACTACGTCGGTTTCGGCCC
GCTCGCGCGCCGCCTGGCCGCTGCGTCCGGCGAGAAGGGCGTGTCGGGTTCGTGCAACAT
CGACGTGGTCTGCCCCGAAGGCGACGGCCGCCGCGACATCATCCGCGCGGTCGGTGCGTA
CTCGAAGAGCGGCACGCTGGCCTGTACCGGTTCGCTGGTCAACAACACCGCCAACGACCG
CAAGATGTACTTCCTGACCGCGCACCACTGCGGCATGGGCACGGCCTCGACCGCCGCGTC
GATCGTGGTGTACTGGAACTATCAGAACTCGACCTGCCGCGCGCCCAACACGCCGGCCAG
CGGCGCCAACGGCGACGGCTCGATGAGCCAGACCCAGTCGGGTTCGACGGTCAAGGCGAC
CTACGCCACCTCCGACTTCACCCTGCTCGAGTTGAACAATGCGGCCAACCCCGCGTTCAA
CCTGTTCTGGGCCGGTTGGGACCGTCGCGACCAGAACTATCCCGGCGCGATCGCCATCCA
CCATCCCAACGTCGCCGAGAAGCGCATCAGCAACTCCACCAGCCCGACCTCGTTCGTGGC
CTGGGGCGGCGGCGCCGGCACCACGCATTTGAACGTGCAGTGGCAGCCCTCGGGCGGCGT
GACCGAGCCGGGTTCGTCGGGTTCGCCGATCTACAGCCCGGAAAAGCGCGTGCTCGGCCA
GCTGCACGGCGGCCCGTCGAGCTGCAGCGCCACCGGCACCAACCGCAGCGACCAGTACGG
CCGCGTGTTCACCTCGTGGACCGGCGGCGGCGCCGCGGCCTCGCGCCTGAGCGATTGGCT
CGATCCGGCCAGCACCGGCGCGCAGTTCATCGACGGCCTGGATTCGGGCGGCGGCACGCC
GAACACTCCGCCGGTGGCGAACTTCACCTCCACCACCAGCGGCCTGACCGCGACCTTCAC
CGACAGCTCCACCGACAGCGACGGTTCGATCGCCTCGCGTAGCTGGAACTTCGGCGACGG
CAGCACCTCGACCGCGACCAACCCGAGCAAGACCTACGCCGCGGCGGGCACCTACACCGT
CACCCTGACGGTCACCGACAACGGCGGCGCCACCAACACCAAGACCGGTTCGGTCACCGT
GTCCGGCGGCCCGGGTGCGCAGACCTACACCAACGACACCGATGTGGCGATCCCGGACAA
CGCGACGGTCGAAAGCCCGATCACCGTGTCCGGCCGCACCGGCAACGGCTCGGCGACCAC
GCCGATCCAGGTGACGATCTACCACACCTACAAGAGCGATCTGAAGGTGGACCTGGTCGC
GCCGGACGGCACCGTCTACAACCTGCACAACCGCACCGGCGGCAGCGCGCACAACATCAT
CCAGACCTTCACCAAGGACCTGTCGAGCGAAGCGGCTCAACG

# Drug_Target_1_General_Function:
Involved in serine-type endopeptidase activity

# Drug_Target_1_General_References:
2492988	Tsunasawa S, Masaki T, Hirose M, Soejima M, Sakiyama F: The primary structure and structural characteristics of Achromobacter lyticus protease I, a lysine-specific serine protease. J Biol Chem. 1989 Mar 5;264(7):3832-9.
2684982	Ohara T, Makino K, Shinagawa H, Nakata A, Norioka S, Sakiyama F: Cloning, nucleotide sequence, and expression of Achromobacter protease I gene. J Biol Chem. 1989 Dec 5;264(34):20625-31.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
6854

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
68124.6

# Drug_Target_1_Name:
Protease 1

# Drug_Target_1_Number_of_Residues:
653

# Drug_Target_1_PDB_ID:
1ARC

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00801	PKD
PF01483	P_proprotein

# Drug_Target_1_Protein_Sequence:
>Protease 1
MKRICGSLLLLGLSISAALAAPASRPAAFDYANLSSVDKVALRTMPAVDVAKAKAEDLQR
DKRGDIPRFALAIDVDMTPQNSGAWEYTADGQFAVWRQRVRSEKALSLNFGFTDYYMPAG
GRLLVYPATQAPAGDRGLISQYDASNNNSARQLWTAVVPGAEAVIEAVIPRDKVGEFKLR
LTKVNHDYVGFGPLARRLAAASGEKGVSGSCNIDVVCPEGDGRRDIIRAVGAYSKSGTLA
CTGSLVNNTANDRKMYFLTAHHCGMGTASTAASIVVYWNYQNSTCRAPNTPASGANGDGS
MSQTQSGSTVKATYATSDFTLLELNNAANPAFNLFWAGWDRRDQNYPGAIAIHHPNVAEK
RISNSTSPTSFVAWGGGAGTTHLNVQWQPSGGVTEPGSSGSPIYSPEKRVLGQLHGGPSS
CSATGTNRSDQYGRVFTSWTGGGAAASRLSDWLDPASTGAQFIDGLDSGGGTPNTPPVAN
FTSTTSGLTATFTDSSTDSDGSIASRSWNFGDGSTSTATNPSKTYAAAGTYTVTLTVTDN
GGATNTKTGSVTVSGGPGAQTYTNDTDVAIPDNATVESPITVSGRTGNGSATTPIQVTIY
HTYKSDLKVDLVAPDGTVYNLHNRTGGSAHNIIQTFTKDLSSEAAQRAPGSCG

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-20

# Drug_Target_1_Specific_Function:
Preferential cleavage:Lys-|-Xaa, including Lys-|-Pro

# Drug_Target_1_SwissProt_ID:
P15636

# Drug_Target_1_SwissProt_Name:
API_ACHLY

# Drug_Target_1_Synonyms:
API
Lysyl endopeptidase
Protease I

# Drug_Target_1_Theoretical_pI:
7.26

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB08603
